Hospital news

WADA Announces CPT Update on COVID-19 Vaccine Recall

New code for the Janssen booster added to the codes created for the Moderna and Pfizer boosters

October 27, 2021 – The American Medical Association (AMA) today announced that the Current procedural terminology (CPT®) The code set has been updated by the CPT’s Editorial Board to include a new code for COVID-19 vaccine booster doses created by Janssen Pharmaceutical Companies of Johnson & Johnson.

New CPT code for Janssen COVID-19 vaccine booster dose joins unique CPT codes already issued booster doses of the COVID-19 vaccine from Moderna and Pfizer. CPT codes for reporting COVID-19 vaccine recalls from Janssen and Moderna have been in effect since October 20. The CPT codes for Pfizer recalls went into effect on September 22. As with all CPT codes related to COVID-19 vaccines, the effective dates coincide with the emergency use authorization issued by the United States Food and Drug Administration (FDA).

“We believe that FDA clearance and CDC recommendations in support of booster doses, including the ability to mix and match booster shots with authorized vaccines, will help provide continued protection against COVID -19 to those who need it most, “said the president of WADA. Gerald E. Harmon, MD

The mix and match option for authorized COVID-19 vaccines and boosters provides the flexibility needed for effective and efficient vaccination programs. The CPT code set is prepared to support this strategy with product-specific CPT codes that clinically distinguish each coronavirus vaccine and booster to facilitate the monitoring, reporting and analysis needed for planning and allocation. based on data as recall programs intensify.

For quick reference, the new code assigned to the Janssen booster for the COVID-19 vaccine is:

0034A Administration of vaccination by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative-free, 5 × 10ten viral particles / 0.5 mL dose; booster dose

The short, medium and long descriptors of all new vaccine-specific CPT codes are available on the the WADA website, as well as other recent changes to the CPT code set that have helped streamline the public health response to SARS-CoV-2 virus and COVID-19 disease.

To help ensure accurate coding and reporting of COVID-19 vaccines and immunization services, WADA is offering a vaccine code lookup resource to help identify the appropriate combination of CPT codes for the type and dose of COVID-19 vaccine provided to each patient.

Changes to the CPT code set are taken into account as part of an open editorial process managed by the CPT Editorial Board which garners broad input from the healthcare community and beyond to ensure that the CPT content reflects the coding requirements of digital health, precision medicine, augmented intelligence, and other aspects of a modern healthcare system. This rigorous editorial process keeps the CPT code set up to date with contemporary medical science and technology so that it can fulfill its vital role as the trusted language of medicine today and code for its future. .

Questions about the coding and content of the CPT should be directed to CPT network, the authoritative source for CPT coding responses. Also check out the AMA online library of COVID-19 CPT Coding and Tips.

About the American Medical Association
The American Medical Association is physicians’ powerful ally in patient care. As the only medical association that brings together more than 190 state and specialty medical corporations and other key stakeholders, WADA represents physicians with a unified voice to all key players in healthcare. WADA leverages its strength in breaking down barriers that interfere with patient care, leading the charge to prevent chronic disease and tackle public health crises, and pushing the future of medicine to meet challenges. biggest challenges in healthcare. For more information visit

Views of the publication: